MedTrace Logo

Effectiveness of Nefopam for Thermoregulation During Surgery

NCT03122665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2020-06-18

No results posted yet for this study

Summary

Nefopam may help blunt thermoregulatory defenses, thus facilitating induction of therapeutic hypothermia

Conditions

  • Hypothermia

Interventions

DRUG

Nefopam Low dose

Continuous intravenous infusion at 0.5 mg/ml for three hours.

DRUG

Nefopam High dose

Continuous intravenous infusion at 1.0 mg/ml for three hours.

Sponsors & Collaborators

  • Laboratoires Biocodex (Montrouge, France)

    collaborator UNKNOWN

  • The Cleveland Clinic

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-08-31
Primary Completion
2006-01-31
Completion
2006-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03122665 on ClinicalTrials.gov